Longeveron Inc. (NASDAQ: LGVN)
$4.02
+0.4950 ( +14.06% ) 28.1M
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.
Market Data
Open
$4.02
Previous close
$3.52
Volume
28.1M
Market cap
$38.60M
Day range
$3.55 - $4.95
52 week range
$0.77 - $36.50
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Sep 13, 2023 |
4 | Insider transactions | 1 | Sep 12, 2023 |
4 | Insider transactions | 1 | Sep 06, 2023 |
4 | Insider transactions | 1 | Aug 22, 2023 |
4 | Insider transactions | 1 | Aug 22, 2023 |
4 | Insider transactions | 1 | Aug 22, 2023 |
8-k | 8K-related | 14 | Aug 18, 2023 |
8-k | 8K-related | 15 | Aug 16, 2023 |
8-k | 8K-related | 14 | Aug 14, 2023 |
10-q | Quarterly Reports | 65 | Aug 11, 2023 |